The Effectiveness of Biofeedback Treatment in Constipated Patients With Idiopathic Parkinson's Disease

Asan Medical Center

Status: Completed

Conditions: Idiopathic Parkinson's Disease; Constipation

Treatments: Other: biofeedback therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00869830

BFT in IPD

Details and patient eligibility

About

The aims of the investigators' study are to characterize the nature of constipation in idiopathic Parkinson's disease (IPD) and to evaluate the usefulness of biofeedback therapy in constipated IPD patients.

Full description

The medical treatment of idiopathic Parkinson's disease (IPD) alleviates constipation symptoms due to the restoration of autonomic dysfunction. However, additional laxatives are usually needed in these patients. Other suppository treatments included stool softeners, dopamine-receptor agonists, botulinum toxins, and prokinetic medications such as tegaserod. Biofeedback therapy (BFT) has been the gold standard for functional constipation with dyssynergic defecation or rectal hyposensitivity. However, researchers have not tried to evaluate its usefulness in constipated IPD patients up to now. The aims of our study are to characterize the nature of constipation in IPD and to evaluate the usefulness of BFT in constipated IPD patients.

Enrollment: 30 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Idiopathic Parkinson's disease

Exclusion criteria

• Secondary Parkinson's disease

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

biofeedback

Experimental group

Treatment:

Other: biofeedback therapy